This week, we have a conversation about clinical trial design with Gen Li, the president and founder of Phesi, a global provider of patient-centric data analysis. Earlier this year, Phesi’s global analysis of all clinical trials conducted in 2023 revealed that more than a quarter (28%) of trials were cancelled during phase II – above the average attrition rate of 20% before 2020. 00:39-01:31: About Phesi01:31-01:49: Is your database global?01:49-03:08: How successful are the different phases of clinical trials?03:08-04:29: What are the biggest challenges for clinical trials currently?04:29-06:23: Are clinical trials improving?06:23-08:14: How can data improve clinical trials?08:14-10:47: How does artificial intelligence affect clinical trial design?10:47-12:53: Can clinical trial costs be reduced?12:53-15:15: Can clinical trial times be shortened? 15:15-18:21: Can data help with clinical trial diversity?18:21-19:46: How can you fill knowledge gaps?19:46-22:01: Do you have less data for rare diseases?22:01-23:28: How does your company help with clinical trial design?23:28-25:12: What kind of solutions can you provide?Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter